<--GAT-->

Proteinuria Lowering Can Adversely Affect Some CKD Patients

by U.S. Medicine

November 6, 2013

MEMPHIS, TN — Proteinuria-lowering interventions in patients with advanced chronic kidney disease (CKD) should be implemented cautiously, considering the potential for adverse outcomes, according to a new study led by researchers from the Memphis, TN, VAMC.

According to the report, published in the Journal of the American College of Cardiology, those patients with the lowest levels of urine microalbumin-creatinine ratio (UACR) experienced higher mortality and worse progression of CKD.1

In general, the authors write, “The risk of adverse outcomes associated with lower levels of proteinuria has been found to be linearly decreasing with even low-normal levels of microalbuminuria.” They say they embarked on their research because it was unclear “whether comorbid conditions change these associations.”

For the study, the researchers examined the association of urine microalbumin-creatinine ratio (UACR) with mortality and the slopes of estimated glomerular filtration rate (eGFR) in a nationally representative cohort of 298,875 VA patients. They focused on associations of UACR with all-cause mortality overall and in subgroups of patients with and without diabetes mellitus, hypertension, cardiovascular disease, congestive heart failure, and advanced CKD.

They found that very low levels of UACR were linearly associated with decreased mortality and less progression of CKD overall: adjusted mortality hazard ratio and estimated glomerular filtration rate slope (95% confidence interval [CI]) associated with UACR ≥200 μg/mg, compared to <5 μg/mg were 1.53 (95% CI: 1.38 to 1.69, p < 0.001) and -1.59 (95% CI: -1.83 to -1.35, p < 0.001).

“Similar linearity was present in all examined subgroups, except in patients with CKD in whom a U-shaped association was present and in whom a UACR of 10 to 19 was associated with the best outcomes,” the authors note, adding, “The association of UACR with mortality and with progressive CKD is modified in patients with CKD, who experience higher mortality and worse progression of CKD with the lowest levels of UACR.”

1. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zadeh K. Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol. 2013 Apr 16;61(15):1626-33. doi: 10.1016/j.jacc.2012.11.071. PubMed PMID: 23500283; PubMed Central PMCID: PMC3625505.


Comments are closed here.


Related Articles

VA Announces Proposed Standards for Access to Mission Act Outside Care

WASHINGTON—VA has released its proposed new access standards, defining new eligibility criteria for veterans seeking care by non-VA providers. The standards are part of the VA MISSION Act signed into law in June 2018, and... View Article

VA Announces New Partnerships to Expand Telehealth Services

WASHINGTON.—VA Secretary Robert Wilkie announced new partnerships with several prominent companies and veterans’ organizations to make access to health services easier for veterans, regardless of their location. Collaborators announced at the recent Anywhere to Anywhere,... View Article


U.S. Medicine Recommends


More From department of veterans affairs

Department of Veterans Affairs (VA)

VA Announces Proposed Standards for Access to Mission Act Outside Care

WASHINGTON—Congress announced last month that it will be opening an investigation into alleged improper influence by three civilian consultants to President Donald Trump on administration of the VA. The three men—Ike Perlmutter, CEO of Marvel... View Article

Department of Veterans Affairs (VA)

VA Announces New Partnerships to Expand Telehealth Services

WASHINGTON—Congress announced last month that it will be opening an investigation into alleged improper influence by three civilian consultants to President Donald Trump on administration of the VA. The three men—Ike Perlmutter, CEO of Marvel... View Article

Department of Veterans Affairs (VA)

VA Fails to Use All Outreach Resources to Combat Veteran Suicide

Despite declaring veteran suicide as its No. 1 clinical priority, VA’s suicide prevention outreach efforts dropped off in 2017 and 2018, and a lack of clear goals and inconsistent leadership has impacted its success, according to a Government Accountability Office report.

Department of Veterans Affairs (VA)

Disabled Veteran Helps Others Like Her Get Back Into the Workforce

Ten years ago, Coniece Washington was walking through the Washington, DC, VA Medical Center when she saw a job notice tacked to a board: certified rehabilitation counselor.

Department of Veterans Affairs (VA)

Senate Blocks Agent Orange Exposure Extension to Blue Water Veterans

Blue Water Navy veterans who claim to be impacted by toxic exposure while serving off the coast of Vietnam were forced to grapple with disappointment once again as the 115th Congress ended without passing legislation addressing their VA benefits.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up